Endurance Wealth Management’s Gossamer Bio GOSS Stock Holding History

Endurance Wealth Management’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$2K	Hold	1,700	–	–	﹤0.01%	599
2023 Q1	$2K	Hold	1,700	–	–	﹤0.01%	598
2022 Q4	$4K	Hold	1,700	–	–	﹤0.01%	538
2022 Q3	$20K	Hold	1,700	–	–	﹤0.01%	406
2022 Q2	$14K	Hold	1,700	–	–	﹤0.01%	455
2022 Q1	$15K	Hold	1,700	–	–	﹤0.01%	483
2021 Q4	$19K	Hold	1,700	–	–	﹤0.01%	448
2021 Q3	$22K	Hold	1,700	–	–	﹤0.01%	440
2021 Q2	$13K	Hold	1,700	–	–	﹤0.01%	500
2021 Q1	$15K	Hold	1,700	–	–	﹤0.01%	489
2020 Q4	$17K	Buy	1,700 +1,000	+143%	+$9.85K	﹤0.01%	436
2020 Q3	$9K	Hold	700	–	–	﹤0.01%	480
2020 Q2	$9K	Hold	700	–	–	﹤0.01%	470
2020 Q1	$7K	Buy	+700	New	+$9.14K	﹤0.01%	453

Other funds holding GOSS

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Endurance Wealth Management's GOSS Position: Q2 2023 in Review

Endurance Wealth Management held its Gossamer Bio (GOSS) position steady in Q2 2023 at 1,700 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #599.

Endurance Wealth Management first reported a position in GOSS in Q1 2020 and has held it in 14 quarters since. The position peaked at $22K in Q3 2021. 99 funds tracked by Wall St. Rank hold GOSS as of Q2 2023.

Endurance Wealth Management held 1,700 shares of Gossamer Bio worth $2K as of Q2 2023.
Endurance Wealth Management left its Gossamer Bio share count unchanged in Q2 2023.
Gossamer Bio made up ﹤0.01% of Endurance Wealth Management's portfolio in Q2 2023, its #599 holding.
Endurance Wealth Management first reported a position in Gossamer Bio in Q1 2020 and has held it in 14 quarters since.
Endurance Wealth Management's Gossamer Bio position peaked at $22K in Q3 2021.
99 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.